ITRAQ-Based Proteomics Investigation of Aqueous Humor from Patients with Coats' Disease

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2016 Jul 15

PMID 27416065

Citations 9

Authors

Qiong Yang

Hai Lu

Xudong Song

Songfeng Li

Wenbin Wei

Affiliations

Soon will be listed here.

Abstract

Background: Coats' disease is an uncommon form of retinal telangiectasis, and the identification of novel proteins that contribute to the development of Coats' disease is useful for improving treatment efficacy. Proteomic techniques have been used to study many eye diseases; however, few studies have used proteomics to study the development of Coats' disease.

Methods: Isobaric tagging for relative and absolute protein quantification (iTRAQ) was employed to screen differentially expressed proteins (DEPs) in the aqueous humor (AH) between stage 3A patients (n = 8), stage 3B patients (n = 14), stage 4 patients (n = 2) and control patients (n = 20). Differentially co-expressed proteins (DCPs) were present in all three stages of Coats' disease and were considered disease-specific proteins. These proteins were further analyzed using Gene Ontology (GO) functional annotations.

Results: A total of 819 proteins were identified in the AH, 222 of which were significantly differentially expressed (fold change > 2 and P < 0.05) in the samples from at least one stage of Coats' disease. Of the DEPs, 46 were found among all three stages of Coats' disease and the controls; therefore, they were considered Coats' disease-specific proteins (DCPs). A GO classification analysis indicated that the DCPs were closely related to structural molecule activity, cell adhesion molecule binding and receptor binding. Western blotting confirmed the expression levels of haptoglobin and apolipoprotein C-I were significantly up-regulated in Coats' disease.

Conclusions: The 46 Coats' disease-specific proteins may provide additional insights into the mechanism of Coats' disease and represent potential biomarkers for identifying individuals with Coats' disease.

Citing Articles

Cardiovascular Disease Risk in Children With Chronic Kidney Disease: Impact of Apolipoprotein C-II and Apolipoprotein C-III.

Chen W, Tain Y, Chen H, Hsu C Front Pediatr. 2021; 9:706323.

PMID: 34458211 PMC: 8397580. DOI: 10.3389/fped.2021.706323.

Comparative Proteomic Investigation of Plasma Reveals Novel Potential Biomarker Groups for Acute Aortic Dissection.

Cheng N, Wang H, Zhang W, Wang H, Jin X, Ma X Dis Markers. 2020; 2020:4785068.

PMID: 32256857 PMC: 7106916. DOI: 10.1155/2020/4785068.

Quantitative proteomic analysis of aqueous humor after rabbit lensectomy reveals differences in coagulation and immunomodulatory proteins.

Young J, Keppel T, Waas M, Salmon A, Buchberger A, Skumatz C Mol Omics. 2020; 16(2):126-137.

PMID: 32031200 PMC: 9620480. DOI: 10.1039/c9mo00169g.

Recent advances in the diagnosis and treatment of Coats' disease.

Yang X, Wang C, Su G Int Ophthalmol. 2019; 39(4):957-970.

PMID: 30895419 DOI: 10.1007/s10792-019-01095-8.

Personalized Proteomics for Precision Health: Identifying Biomarkers of Vitreoretinal Disease.

Velez G, Tang P, Cabral T, Cho G, Machlab D, Tsang S Transl Vis Sci Technol. 2018; 7(5):12.

PMID: 30271679 PMC: 6159735. DOI: 10.1167/tvst.7.5.12.

References

Theoulakis P, Halki A, Petropoulos I, Katsimpris J . Coats disease in a 14-year-old boy treated with intravitreal ranibizumab and retinal laser photocoagulation. Klin Monbl Augenheilkd. 2012; 229(4):447-50. DOI: 10.1055/s-0031-1299216. View

Xu D, Deng D, Li X, Wei L, Li Y, Yang X . Discovery and identification of serum potential biomarkers for pulmonary tuberculosis using iTRAQ-coupled two-dimensional LC-MS/MS. Proteomics. 2013; 14(2-3):322-31. DOI: 10.1002/pmic.201300383. View

Fleenor D, Shepard A, Hellberg P, Jacobson N, Pang I, Clark A . TGFbeta2-induced changes in human trabecular meshwork: implications for intraocular pressure. Invest Ophthalmol Vis Sci. 2005; 47(1):226-34. DOI: 10.1167/iovs.05-1060. View

Tawara A, Okada Y, Kubota T, Suzuki Y, Taniguchi F, Shirato S . Immunohistochemical localization of MYOC/TIGR protein in the trabecular tissue of normal and glaucomatous eyes. Curr Eye Res. 2001; 21(6):934-43. DOI: 10.1076/ceyr.21.6.934.6988. View

Zhao Q, Peng X, Chen F, Zhang Y, Wang L, You Q . Vascular endothelial growth factor in Coats' disease. Acta Ophthalmol. 2013; 92(3):e225-8. DOI: 10.1111/aos.12158. View

Wu W, Wang G, Baek S, Shen R . Comparative study of three proteomic quantitative methods, DIGE, cICAT, and iTRAQ, using 2D gel- or LC-MALDI TOF/TOF. J Proteome Res. 2006; 5(3):651-8. DOI: 10.1021/pr050405o. View

Jin G, Li Y, Cong W, Yu H, Dong H, Shu H . iTRAQ-2DLC-ESI-MS/MS based identification of a new set of immunohistochemical biomarkers for classification of dysplastic nodules and small hepatocellular carcinoma. J Proteome Res. 2011; 10(8):3418-28. DOI: 10.1021/pr200482t. View

Elsobky S, Crane A, Margolis M, Carreon T, Bhattacharya S . Review of application of mass spectrometry for analyses of anterior eye proteome. World J Biol Chem. 2014; 5(2):106-14. PMC: 4050106. DOI: 10.4331/wjbc.v5.i2.106. View

Travis G, Golczak M, Moise A, Palczewski K . Diseases caused by defects in the visual cycle: retinoids as potential therapeutic agents. Annu Rev Pharmacol Toxicol. 2006; 47:469-512. PMC: 2442882. DOI: 10.1146/annurev.pharmtox.47.120505.105225. View

10.

Ozcan A, Ozdemir N, Canataroglu A . The aqueous levels of TGF-beta2 in patients with glaucoma. Int Ophthalmol. 2004; 25(1):19-22. DOI: 10.1023/b:inte.0000018524.48581.79. View

11.

Muurling M, van den Hoek A, Mensink R, Pijl H, Romijn J, Havekes L . Overexpression of APOC1 in obob mice leads to hepatic steatosis and severe hepatic insulin resistance. J Lipid Res. 2003; 45(1):9-16. DOI: 10.1194/jlr.M300240-JLR200. View

12.

Avery C, He Q, North K, Ambite J, Boerwinkle E, Fornage M . A phenomics-based strategy identifies loci on APOC1, BRAP, and PLCG1 associated with metabolic syndrome phenotype domains. PLoS Genet. 2011; 7(10):e1002322. PMC: 3192835. DOI: 10.1371/journal.pgen.1002322. View

13.

Ridley M, Shields J, Brown G, Tasman W . Coats' disease. Evaluation of management. Ophthalmology. 1982; 89(12):1381-7. DOI: 10.1016/s0161-6420(82)34634-5. View

14.

Crouch R, Chader G, Wiggert B, Pepperberg D . Retinoids and the visual process. Photochem Photobiol. 1996; 64(4):613-21. DOI: 10.1111/j.1751-1097.1996.tb03114.x. View

15.

Skinner N, Wroblewski M, Kirihara J, Nelsestuen G, Seaquist E . Sitagliptin Results in a Decrease of Truncated Apolipoprotein C1. Diabetes Ther. 2015; 6(3):395-401. PMC: 4575309. DOI: 10.1007/s13300-015-0123-1. View

16.

Shields J, Shields C, Honavar S, Demirci H . Clinical variations and complications of Coats disease in 150 cases: the 2000 Sanford Gifford Memorial Lecture. Am J Ophthalmol. 2001; 131(5):561-71. DOI: 10.1016/s0002-9394(00)00883-7. View

17.

Zhang H, Liu Z . Increased nitric oxide and vascular endothelial growth factor levels in the aqueous humor of patients with coats' disease. J Ocul Pharmacol Ther. 2012; 28(4):397-401. DOI: 10.1089/jop.2011.0168. View

18.

Rask L, Peterson P . In vitro uptake of vitamin A from the retinol-binding plasma protein to mucosal epithelial cells from the monkey's small intestine. J Biol Chem. 1976; 251(20):6360-6. View

19.

He Y, Wang H, Zhao B, Lee J, Bahl D, McCluskey J . Elevated vascular endothelial growth factor level in Coats' disease and possible therapeutic role of bevacizumab. Graefes Arch Clin Exp Ophthalmol. 2010; 248(10):1519-21. DOI: 10.1007/s00417-010-1366-1. View

20.

Morris B, Foot B, Mulvihill A . A population-based study of Coats disease in the United Kingdom I: epidemiology and clinical features at diagnosis. Eye (Lond). 2010; 24(12):1797-801. DOI: 10.1038/eye.2010.126. View